The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Cravath, Swaine & Moore LLP

WORLDWIDE PLAZA, 825 EIGHTH AVENUE, 10019-7475, USA
Tel:
Work +1 212 474 1000
Fax:
Fax +1 212 474 3700
Email:
Web:
www.cravath.com
London, NEW YORK

David Kappos

Tel:
Work +1 (212) 474-1168
Email:
Web:
www.cravath.com/dkappos/
Cravath, Swaine & Moore LLP

Work Department

Corporate

Position

David J. Kappos is a partner at Cravath. He is widely recognized as one of the world’s foremost leaders in the field of intellectual property, including intellectual property management and strategy, the development of global intellectual property norms, laws and practices as well as commercialization and enforcement of innovation‑based assets. Mr. Kappos supports the Firm’s clients with a wide range of their most complex intellectual property issues, including those pertaining to blockchain and financial technology (FinTech).


United States: Intellectual property

Patents: litigation (full coverage)

Within: Patents: litigation (full coverage)

Cravath, Swaine & Moore LLP in New York has particular strengths in the pharmaceuticals and telecoms sectors. On the pharmaceuticals side, Keith Hummel and David Greenwald defended Amgen in pioneering BPCIA litigation brought by AbbVie in 2016, alleging infringement of ten AbbVie patents by Amgen's Amjevita, a biosimilar to blockbuster drug Humira. On the telecoms side, the group represents Qualcomm in a series of suits regarding modem chips, including several cases against Apple and a case against the Federal Trade Commission concerning an alleged breach of Section 5 of the Federal Trade Act. A major technology highlight was the successful representation of Alarm.com in a Federal Circuit case following IPRs against Vivint, which had filed for patent infringement of home security technology patents. Other notable instructions came from DRI Capital, Juno Therapeutics and OrbusNeich. Richard Stark, David Kappos, David Greenwald and chairman Evan Chesler are other names to note. Vanessa Lavely made partner, and former US district judge Katherine Forrest joined the team.

[back to top]

United States: Media, technology and telecoms

Fintech

Within: Fintech

The New York-based blockchain and financial technology team at Cravath, Swaine & Moore LLP fields a multidisciplinary team leveraging corporate, M&A, capital markets, financing, tax, intellectual property and litigation expertise. The group frequently acts for IBM in connection with investments into financial technology companies and advised the client on the formation of TradeLens, a blockchain-enabled shipping solution which was jointly developed by Maersk and IBM. Other recent work ranges from acting for financial technology solutions company DH Corporation on its C$4.8bn sale to Vista Equity Partner and representing American Express (AmEx) in litigation relating to allegations that AmEx and numerous other issuers of credit and charge cards conspired to shift certain costs of fraudulent charges from the card issuers to merchants. Other clients include FactSet and JPMorgan; the group is assisting the former with the $265m acquisition of automated trading solutions developer Portware and acted for the latter in connection with the arrangement of credit facilities totaling $7.55bn made available to Automatic Data Processing. Intellectual property expert David Kappos has particular experience advising on blockchain issues. Corporate partners Scott Bennett and Michael Mariani are other key names to note.

[back to top]

Technology transactions

Within: Technology transactions

Cravath, Swaine & Moore LLP has extensive experience advising blockchain, media, biotech and software companies on matters including joint venture and M&A-driven technology licensing deals and development contracts involving cybersecurity and artificial intelligence. Faiza J. Saeed and practice co-head David J. Kappos, who are both based in New York, are advising The Walt Disney Company in connection with its pending $85bn acquisition of 21st Century Fox, which involves agreements for a multitude of copyright-based domain names and film production technology. Kappos also advised Biogen on its expansion of its existing agreement with pharmaceuticals company Eisai to jointly develop and commercialize certain Alzheimer’s disease treatments. Other New York contacts include Keith Hallam and practice co-head George F. Schoen, the latter of whom acted for Warner Media in its investment in NewTV as a part of its $1bn initial funding round. Allison M. Wein was promoted to partner in January 2019.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to